Iron Overload
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Liver volume, peripheral hemogram, bone marrow pathology, serum iron, serum ferritin, pathological iron deposition in multiple organs (liver, bone marrow, spleen), liver hepcidin, and bone morphogenetic protein 6 (BMP6), SMAD family member 4 (SMAD4) and transferrin receptor 2 (TfR2) mRNA expression levels were compared among the normal control, AA, iron overload and composite model groups to validate the composite model, and explore the pathogenesis and features of iron overload in this model.
|
29434729 |
2018 |
Iron Overload
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that assignment of disease causation in clinical cases of iron overload to pro-peptide variants in BMP6 should thus be treated with caution and requires biological characterization.
|
29695288 |
2018 |
Iron Overload
|
0.390 |
Biomarker
|
disease |
BEFREE |
The patients' clinical phenotypes were similar to that of other patients with BMP6-related IO recently described.
|
28335084 |
2017 |
Iron Overload
|
0.390 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We identified 3 heterozygous missense mutations in BMP6 in patients with unexplained iron overload.
|
26582087 |
2016 |
Iron Overload
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Influence of excess iron and BMP6 on GPR91 expression was investigated in ARPE-19 cells, and wild-type and Hjv(-/-) pRPE cells.
|
27046124 |
2016 |
Iron Overload
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
We identified 3 heterozygous missense mutations in BMP6 in patients with unexplained iron overload.
|
26582087 |
2016 |
Iron Overload
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
The data suggested that liver iron overload was an important stimuli for hepcidin synthesis, stronger than the inhibitory effect of high rHuEPO doses; moreover, the findings raised the hypothesis that when high inflammation (triggering hepcidin expression) was associated with increased iron stores in hemodialysis patients, hepcidin expression was also upregulated via BMP6, enhancing hepcidin synthesis, leading, therefore, to worsening of anemia and, eventually, to a hyporesponse/resistance to rHuEPO therapy.© 2016 BioFactors, 42(3):296-306, 2016.
|
26990350 |
2016 |
Iron Overload
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Hepatic expression of BMP6 was appropriately elevated in HFE-HH compared to controls (P = 0.02), likely related to iron overload.
|
20658468 |
2010 |
Iron Overload
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
The iron burden in Bmp6 mutant mice is significantly greater than that in mice deficient in the gene associated with classical hemochromatosis (Hfe), suggesting that mutations in BMP6 might cause iron overload in humans with severe juvenile hemochromatosis for which the genetic basis has not yet been characterized.
|
19252488 |
2009 |
Iron Overload
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload.
|
19252486 |
2009 |
Hemochromatosis
|
0.350 |
Biomarker
|
disease |
BEFREE |
Endothelial Bmp2 knockout exacerbates hemochromatosis in Hfe knockout mice but not Bmp6 knockout mice.
|
31778583 |
2019 |
Hemochromatosis
|
0.350 |
Biomarker
|
disease |
BEFREE |
Loss of Bmp6 in ECs recapitulated the hemochromatosis phenotype of global Bmp6 knockout mice, whereas hepatocyte and macrophage Bmp6 conditional knockout mice exhibited no iron phenotype.
|
27864295 |
2017 |
Hemochromatosis
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
We sequenced the BMP6 gene in 70 consecutive patients with a moderate increase in serum ferritin and liver iron levels who did not carry genetic variants associated with hemochromatosis.
|
26582087 |
2016 |
Hemochromatosis
|
0.350 |
Biomarker
|
disease |
BEFREE |
G-protein-coupled receptor 91 is a BMP6 target and Hjv deletion enhances BMP signaling in retina, thus underscoring a role for excess iron and hemochromatosis in abnormal retinal vascularization.
|
27046124 |
2016 |
Hemochromatosis
|
0.350 |
Biomarker
|
disease |
CTD_human |
Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload.
|
19252486 |
2009 |
Hemochromatosis
|
0.350 |
Biomarker
|
disease |
CTD_human |
The iron burden in Bmp6 mutant mice is significantly greater than that in mice deficient in the gene associated with classical hemochromatosis (Hfe), suggesting that mutations in BMP6 might cause iron overload in humans with severe juvenile hemochromatosis for which the genetic basis has not yet been characterized.
|
19252488 |
2009 |
Hemochromatosis
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
The iron burden in Bmp6 mutant mice is significantly greater than that in mice deficient in the gene associated with classical hemochromatosis (Hfe), suggesting that mutations in BMP6 might cause iron overload in humans with severe juvenile hemochromatosis for which the genetic basis has not yet been characterized.
|
19252488 |
2009 |
Hereditary hemochromatosis
|
0.330 |
Biomarker
|
disease |
BEFREE |
The exploration of genetic hemochromatosis has revealed the involvement of several genes, including the recently described BMP6.
|
28694024 |
2017 |
Hereditary hemochromatosis
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Hepatic expression of BMP6 was appropriately elevated in HFE-HH compared to controls (P = 0.02), likely related to iron overload.
|
20658468 |
2010 |
Hereditary hemochromatosis
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload.
|
19252486 |
2009 |
Hereditary hemochromatosis
|
0.330 |
Biomarker
|
disease |
CTD_human |
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.
|
19252486 |
2009 |
Hereditary hemochromatosis
|
0.330 |
Biomarker
|
disease |
CTD_human |
Lack of the bone morphogenetic protein BMP6 induces massive iron overload.
|
19252488 |
2009 |
Colorectal Carcinoma
|
0.320 |
PosttranslationalModification
|
disease |
BEFREE |
The study revealed BMP6 hypermethylation in 34 of 85 tumor specimens (40%), and 15 out of 45 normal tissue samples from CRC (33%).
|
25227796 |
2014 |
Colorectal Carcinoma
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
We further confirmed that BMP6 activity could be used as a prognostic indicator in prostate, bladder and colorectal cancers, using publicly available data on BMP6, noggin and SOST mRNA expression and patient survival.
|
22364398 |
2012 |
Colorectal Carcinoma
|
0.320 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|